Delivery Order SPE2DB22D1202-SPE2DB25FVBD5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,577.55 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100, with an ultimate completion date of October 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's established role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,174.34 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count packaging) under a firm fixed-price contract. The award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor...
- The Defense Logistics Agency awarded a delivery order valued at $9,201.03 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by November 4, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $3,846.63 for Glimepiride 4 mg tablets (100-count units) on April 30, 2025, with an ultimate completion date of May 1, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,375.62 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. The contract utilizes firm fixed price pricing and was competitively awarded without a set-aside designation. The order was awarded on October 16, 2025, with an ultimate completion date of October 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $5,207.80 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100. The contract, with an ultimate completion date of May 28, 2025, represents a competitively awarded, non-set-aside procurement with performance location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Glimepiride 4 mg tablets (100 count) with a ceiling value of $2,377.11. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is set for ultimate completion by July 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,207.23 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 2, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The place of performance is the vendor's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,157.52 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,963.15 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) on September 22, 2025, with completion scheduled for September 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVBD5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,217.54 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order under its broader relationship with the Defense Logistics Agency's medical supply chain. This delivery order represents a discrete transaction within AmerisourceBergen Drug Corp's significant federal contract portfolio supporting military and veteran healthcare systems. The contractor holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026, which serves as the prime vehicle enabling supply of a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs globally. The firm's ability to secure competitive awards across multiple therapeutic domains, including diabetes medications and other critical pharmaceuticals, demonstrates its established capability to meet federal medical procurement standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 5/30/25 |